MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/1471-2407-11-492

Медицинская библиотека · BMC cancer · 2011

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.

He Jian, Zeng Zhao-Chong, Fan Jia, Zhou Jian, Sun Jing, Chen Bing, Yang Ping, Wang Bin-Liang, Zhang Bo-Heng, Zhang Jian-Ying

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Little is known about the clinical features and prognostic factors of bone metastases of hepatocellular carcinoma (HCC) following liver transplantation (LT).

METHODS

All adult patients undergoing LT from 2001 to 2010 were reviewed. Patients with HCC bone metastases after LT received external beam radiotherapy(EBRT) during this period. Demographic variables, laboratory values, and tumor characteristics were determined before LT and EBRT. Total radiation dose ranged from 8 to 60 Gy(median dose 40.0 Gy).

RESULTS

The trunk was the most common site of bone metastases with finding of expansile soft-tissue masses in 23.3% of patients. Overall pain relief from EBRT occurred in 96.7% (29/30). No consistent dose-response relationship was found for palliation of with doses between 30 and 56 Gy (P = 0.670). The median survivals from the time of bone metastases was 8.6 months. On univariate and multivariate analyses, better survival was significantly associated with a better Karnofsky performance status (KPS) and well-controlled intrahepatic tumor, but not with lower alpha-fetoprotein levels. The median time from LT to bone metastases was 7.1 months. Patients exceeding the Shanghai criteria presented with bone metastases earlier than those within the Fudan criteria. Patients with soft-tissue extension always had later bone metastases. The majority of deaths were caused by liver failure due to hepatic decompensation or tumor progression.

CONCLUSION

The prognostic factors of bone metastases of HCC following LT are KPS and well-controlled intrahepatic. Even though survival is shorter for these patients, EBRT provides effective palliation of pain.

Для цитирования: He Jian, Zeng Zhao-Chong, Fan Jia, Zhou Jian, Sun Jing, Chen Bing, Yang Ping, Wang Bin-Liang, Zhang Bo-Heng, Zhang Jian-Ying. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.. BMC cancer. 2011. DOI: 10.1186/1471-2407-11-492.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.